All Pathways
PsychiatryEmergency

Acute Dystonia & Extrapyramidal Symptoms (EPS) Management

Acute Dystonia & Extrapyramidal Symptoms (EPS) Management: Suspected EPS/Acute Dystonia → Identify Type of EPS → ⚠️ ACUTE DYSTONIA → Immediate Treatment...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected EPS/Acute Dystonia

    Patient on dopamine-blocking agent with movement disorder

    1. Decision

      Identify Type of EPS

      Different syndromes require different management

      1. Warning

        ⚠️ ACUTE DYSTONIA

        Sustained muscle contractions - EMERGENCY

        • Onset: Within 48-72 hours of starting/increasing dose
        • 90% occur within first 5 days
        • Torticollis (neck twisting)
        • Oculogyric crisis (eyes rolled back)
        • Trismus (jaw clenching)
        • Laryngeal dystonia (stridor - AIRWAY EMERGENCY)
        • Opisthotonos (arched back)
        1. Action

          Immediate Treatment

          Anticholinergic reversal

          • BENZTROPINE 1-2mg IM or IV
          • - Onset: 5-15 minutes
          • - Can repeat in 30 min if needed
          • OR DIPHENHYDRAMINE 25-50mg IM or IV
          • - Alternative if benztropine unavailable
          • Relief usually within minutes
          • ⚠️ If laryngeal dystonia: Secure airway first!
          1. Action

            Prophylaxis After Dystonia

            Prevent recurrence

            • Continue oral anticholinergic 48-72 hours
            • Benztropine 1-2mg BID or
            • Trihexyphenidyl 2mg BID
            • Consider prophylaxis when starting high-potency AP
            • Risk factors: young, male, high-potency FGA
            1. Decision

              Need to Continue Antipsychotic?

              Evaluate ongoing need

              1. Action

                Consider Switching Antipsychotic

                Lower EPS risk options

                • Quetiapine (low EPS risk)
                • Clozapine (lowest EPS risk)
                • Aripiprazole (partial agonist)
                • Avoid high-potency FGAs if EPS history
                1. Action

                  Ongoing Monitoring

                  Use standardized scales

                  • AIMS (Abnormal Involuntary Movement Scale) q3-6mo
                  • Barnes Akathisia Rating Scale
                  • Simpson-Angus Scale for parkinsonism
                  • Monitor for tardive dyskinesia (chronic EPS)
                  1. Outcome

                    EPS Managed

                    Ongoing prevention and monitoring

                    • Educate patient about EPS recognition
                    • Carry anticholinergic if high-risk
                    • Regular movement disorder screening
                    • Early intervention prevents complications
      2. Action

        Akathisia

        Inner restlessness, inability to sit still

        • Onset: Days to weeks after starting
        • Subjective inner restlessness
        • Pacing, rocking, inability to sit
        • Can be misdiagnosed as anxiety/agitation
        • Associated with suicidality if untreated
        1. Action

          Akathisia Treatment

          Beta-blockers or benzodiazepines

          • First-line: PROPRANOLOL 10-20mg TID
          • - Most evidence; well-tolerated
          • Alternative: LORAZEPAM 0.5-1mg BID-TID
          • Consider reducing antipsychotic dose
          • Anticholinergics less effective for akathisia
          • Mirtazapine 15mg may help
      3. Action

        Drug-Induced Parkinsonism

        Bradykinesia, rigidity, tremor

        • Onset: Weeks to months
        • Tremor (pill-rolling, resting)
        • Cogwheel rigidity
        • Bradykinesia
        • Masked facies
        • Shuffling gait
        1. Action

          Parkinsonism Treatment

          Anticholinergics or dose reduction

          • Reduce antipsychotic dose if possible
          • Switch to lower D2-binding SGA
          • BENZTROPINE 0.5-2mg BID
          • - Or trihexyphenidyl 2-5mg BID-TID
          • AMANTADINE 100mg BID alternative
          • Monitor for anticholinergic side effects

Guideline Source

Extrapyramidal Side Effects Management - StatPearls/Standard Protocols

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Acute dystonia requires immediate treatment - can be life-threatening (laryngeal)
  • Must differentiate from other causes of abnormal movements
  • Tardive dyskinesia requires different management
  • Some EPS may not respond fully to anticholinergics

Applicable Regions

USEUGlobal
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management?

The Acute Dystonia & Extrapyramidal Symptoms (EPS) Management is a emergency clinical algorithm for Psychiatry. It provides a structured decision tree to guide clinical decision-making, based on Extrapyramidal Side Effects Management - StatPearls/Standard Protocols.

What guideline is the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management based on?

This algorithm is based on Extrapyramidal Side Effects Management - StatPearls/Standard Protocols.

What are the limitations of the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management?

Known limitations include: Acute dystonia requires immediate treatment - can be life-threatening (laryngeal); Must differentiate from other causes of abnormal movements; Tardive dyskinesia requires different management; Some EPS may not respond fully to anticholinergics. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Acute Dystonia & Extrapyramidal Symptoms (EPS) Management appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free